Dr Catherine Mummery oversees novel therapeutics at the UCL Dementia Research Centre and is also a Consultant Neurologist at the National Hospital for Neurology and Neurosurgery.

She is leading a world-first trial involving a ‘gene silencing’ drug (BIIB080) that has shown promise in safely and successfully lowering levels of the harmful tau protein known to cause Alzheimer's disease.

Alongside her work in finding new treatments, Dr Mummery is also working on a groundbreaking trial that would enable MRI scans to be completed in a fraction of the time they currently are.

Learn more about UCL's interdisciplinary approach to dementia here.

Dr Julia Shaw is an honorary research associate in UCL’s Division of Psychology and Language Sciences (PALS). She specialises in criminal psychology and is the author of multiple best-selling books.

Learn more about Dr Shaw here: https://www.ucl.ac.uk/brain-sciences/news/2023/jun/journey-understanding-why-people-do-bad-things-dr-julia-shaw

And you can purchase her books here: https://www.drjuliashaw.com/

Oliver Robinson is a Professor of Neuroscience and Mental Health at the Institute of Cognitive Neuroscience. He’s never been more excited about the work his team are conducting at the Anxiety Lab.

In this episode we talk about the difference between anxiety and fear, the gap in treatments for anxiety conditions, exciting innovations in neuroimaging and computational psychiatry, and why UCL is a great place to study mental health.

Hosted on Acast. See acast.com/privacy for more information.